MedTrace Logo

Alveolar Ridge Preservation Procedures

NCT05419778 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2022-07-08

No results posted yet for this study

Summary

Tooth loss is accompanied by different patterns of bone loss. Up to 50% loss of alveolar crestal bone width will likely occur 1 year after tooth loss, especially in the anterior maxilla. A great percentage of the process of alveolar bone resorption occurs within the first 3 to 6 months post-extraction. If ridge preservation is not conducted, 40%-60% of the total alveolar bone volume is lost during the first 2-3 years post-extraction, and this phenomenon has shown to continue to occur at a rate of 0.25%-0.5% loss per year. It has been proposed that ridge augmentation procedures may reduce the expected ridge reduction after tooth loss. Ridge augmentation procedures may require the use of bone grafts and non-resorbable or non-resorbable barrier membranes. The use of non-resorbable barrier membranes for ridge augmentation has the clinical disadvantage of needing a second procedure for its removal during the healing phase. Osteogen® plug (OPP) consists of a non-ceramic bone graft incorporated in type I bovine Achilles tendon collagen. OPP was first developed to serve as a one-step grafting solution for ridge preservation without the need for a barrier membrane

Conditions

  • Alveolar Ridge Preservation

Interventions

DEVICE

Osteogen plug®

A type I bovine Achilles tendon collagen with bioactive resorbable calcium apatite crystals (CCAC)

DEVICE

MInerOss®

A cortico-cancellous bone chips mix with polytetrafluoroethylene (dPTFE)(Cytoplast) barrier membrane.

Sponsors & Collaborators

  • University of Tennessee

    lead OTHER

Principal Investigators

  • Cimara F Ferreira, PhD · University of Tennessee

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-08
Primary Completion
2021-01-06
Completion
2021-01-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05419778 on ClinicalTrials.gov